Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pearlly Yan

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Alzheimer'S Research & Therapy|February 7, 2024
DNA hypomethylation promotes the expression of CASPASE-4 which exacerbates inflammation and amyloid-β deposition in Alzheimer's diseaseKylene P Daily, Asmaa Badr, Mostafa Eltobgy, et al.
Leukemia|November 14, 2022
VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemiaSteven Sher, Ethan Whipp, Janek Walker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2021
Targeting DNA Damage Repair Functions of Two Histone Deacetylases, HDAC8 and SIRT6, Sensitizes Acute Myeloid Leukemia to NAMPT InhibitionPu Zhang, Lindsey T Brinton, Katie Williams, et al.
Brain, Behavior, and Immunity|May 8, 2024
Microglia-targeted inhibition of miR-17 via mannose-coated lipid nanoparticles improves pathology and behavior in a mouse model of Alzheimer's diseaseAsmaa Badr, Kylene P Daily, Mostafa Eltobgy, et al.
Cell Research|May 9, 2015
Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeuticsGi-Bang Koo, Michael J Morgan, Da-Gyum Lee, et al.
Blood|November 17, 2021
PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemiaSwagata Goswami, Rajeswaran Mani, Jessica Nunes, et al.
Nature Communications|November 4, 2021
Rare t(X;14)(q28;q32) translocation reveals link between MTCP1 and chronic lymphocytic leukemiaJanek S Walker, Zachary A Hing, Steven Sher, et al.
The Journal of Clinical Investigation|July 12, 2022
Genome-wide DNA hypermethylation opposes healing in patients with chronic wounds by impairing epithelial-mesenchymal transitionKanhaiya Singh, Yashika Rustagi, Ahmed S Abouhashem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2014
Epigenetics meets genetics in acute myeloid leukemia: clinical impact of a novel seven-gene scoreGuido Marcucci, Pearlly Yan, Kati Maharry, et al.
Cancer Research|November 4, 2018
Adipokines Deregulate Cellular Communication via Epigenetic Repression of <i>Gap Junction</i> Loci in Obese Endometrial CancerSrikanth R Polusani, Yi-Wen Huang, Guangcun Huang, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Alzheimer'S Research & Therapy|February 7, 2024
DNA hypomethylation promotes the expression of CASPASE-4 which exacerbates inflammation and amyloid-β deposition in Alzheimer's diseaseKylene P Daily, Asmaa Badr, Mostafa Eltobgy, et al.
Leukemia|November 14, 2022
VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemiaSteven Sher, Ethan Whipp, Janek Walker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2021
Targeting DNA Damage Repair Functions of Two Histone Deacetylases, HDAC8 and SIRT6, Sensitizes Acute Myeloid Leukemia to NAMPT InhibitionPu Zhang, Lindsey T Brinton, Katie Williams, et al.
Brain, Behavior, and Immunity|May 8, 2024
Microglia-targeted inhibition of miR-17 via mannose-coated lipid nanoparticles improves pathology and behavior in a mouse model of Alzheimer's diseaseAsmaa Badr, Kylene P Daily, Mostafa Eltobgy, et al.
Cell Research|May 9, 2015
Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeuticsGi-Bang Koo, Michael J Morgan, Da-Gyum Lee, et al.
Blood|November 17, 2021
PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemiaSwagata Goswami, Rajeswaran Mani, Jessica Nunes, et al.
Nature Communications|November 4, 2021
Rare t(X;14)(q28;q32) translocation reveals link between MTCP1 and chronic lymphocytic leukemiaJanek S Walker, Zachary A Hing, Steven Sher, et al.
The Journal of Clinical Investigation|July 12, 2022
Genome-wide DNA hypermethylation opposes healing in patients with chronic wounds by impairing epithelial-mesenchymal transitionKanhaiya Singh, Yashika Rustagi, Ahmed S Abouhashem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2014
Epigenetics meets genetics in acute myeloid leukemia: clinical impact of a novel seven-gene scoreGuido Marcucci, Pearlly Yan, Kati Maharry, et al.
Cancer Research|November 4, 2018
Adipokines Deregulate Cellular Communication via Epigenetic Repression of <i>Gap Junction</i> Loci in Obese Endometrial CancerSrikanth R Polusani, Yi-Wen Huang, Guangcun Huang, et al.
Pageof 8